STN1013800

N/A

Report date: 2025/04/20 20:00:03

Base Information

Drug NameSTN1013800
Drug Alias NameSTN1013800
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBlepharoptosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSanten Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsBlepharoptosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A